# Gaudium IVF

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/gaudium-ivf
Canonical HTML page: https://getbiobrief.com/entity/gaudium-ivf

## Timeline

- **2026-02-24**: Final Bidding Day — The bidding process concludes with a 6.33% GMP trend.
- **2026-02-23**: Day 2 Milestone — Subscription reaches 3x overall with strong retail participation.
- **2026-02-20**: IPO Opens — Gaudium IVF opens its initial public offering for subscription.

## Recent coverage (1 stories)

### Gaudium IVF IPO Enters Final Day with 3x Subscription and Positive GMP
2026-02-24 04:36:20 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Gaudium IVF and Women Health has reached its final day of bidding with an overall subscription of three times as of the end of Day 2. The offering is seeing strong retail interest and maintains a 6.33% grey market premium, signaling a positive market debut.
Full story: https://getbiobrief.com/story/gaudium-ivf-ipo-day-3-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.